What triggers Fibrinogen to produce Fibrin?

By SWA

Fibrinogen is a soluble macromolecule, but forms an insoluble clot or gel on conversion to fibrin by the action of the serine protease thrombin, which is activated by a cascade of enzymatic reactions triggered by vessel wall injury, activated blood cells, or a foreign surface.

Fibrinogen is converted into fibrin primarily by the enzyme thrombin during the blood clotting process. This conversion is a crucial step in the formation of a blood clot, which helps stop bleeding at a wound site.

Here's how the process works:

  1. Injury and Activation of the Clotting Cascade: When a blood vessel is injured, the body initiates a complex series of reactions known as the coagulation or clotting cascade. This cascade involves the activation of various clotting factors, which are proteins that work in a sequence to form a clot.

  2. Formation of Thrombin: During the clotting cascade, prothrombin (Factor II) is activated to form thrombin (Factor IIa) by Factor Xa, which is part of the prothrombinase complex.

  3. Conversion of Fibrinogen to Fibrin: Thrombin then acts on fibrinogen, a soluble plasma protein, by cleaving specific peptide bonds. This cleavage removes small fibrinopeptides from fibrinogen, converting it into fibrin monomers.

  4. Formation of a Fibrin Mesh: The fibrin monomers spontaneously polymerize (link together) to form long strands of insoluble fibrin. These fibrin strands then weave together to form a stable mesh or network that traps blood cells, effectively creating a clot that seals the wound.

  5. Stabilization of the Clot: Finally, the enzyme Factor XIII (fibrin-stabilizing factor), which is also activated by thrombin, cross-links the fibrin strands, strengthening the clot and making it more resistant to breakdown.

Thus, thrombin is the key enzyme that triggers the transformation of fibrinogen into fibrin, which is essential for clot formation and wound healing.

 

Comments

Post a Comment

Popular posts from this blog

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By SWA
Image
Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially presenting as petechiae, diagnosed by a rheumatologist. However, following the second dose, symptoms rapidly escalated, resulting in intense burning pain and thinning of the skin. The skin on the legs and thighs became paper-thin and could tear with the slightest touch, with the affected area e...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By SWA
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By SWA
Image
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more